GRANTHAM MAYO VAN OTTERLOO & CO LLC

Investment decisions are overseen by a team of senior partners including Ben Inker (Head of Asset Allocation) and Tom Hancock (Portfolio Manager). Jeremy Grantham remains a co-founder and a major voice but has stepped back from day-to-day management. The firm's investment committee drives tactical allocations across equity, fixed income, and alternative strategies (per public record).

GMO operates both as an institutional asset manager with registered funds (UCITS, mutual funds in the US) and as a multi-family office for wealthy families. It manages separate accounts for institutions and RIAs, while also providing bespoke portfolio management for a select group of family-office clients. The multi-family office arm is not open to unaccredited investors.

GMO's proprietary research team, known for deep due diligence on resource scarcity, commodity cycles, and value anomalies, identifies alpha in public equities and alternatives. The firm also participates in co-investments alongside its family-office clients, but specific deal sources are not publicly disclosed beyond its asset-allocation research.

GMO's core asset classes include US and international equities, fixed income (both investment grade and high yield), real estate, hedge funds, and private credit. The firm has historically focused on value, quality, and resource-investing themes. Its current allocation decisions are influenced by long-cycle thesis on inflation and demographic shifts.

Yes, the GMO Foundation, established as a separate 501(c)(3) entity, supports environmental conservation, climate research, and social equity. Philanthropic decisions are made independently from GMO's investment operations, though the Foundation's endowment is managed by GMO. Jeremy Grantham has been a major personal donor to environmental causes through his own foundation.